Cost-Utility Analysis of Dolutegravir- Versus Efavirenz-Based Regimens as a First-Line Treatment in Adult HIV/AIDS Patients in Ethiopia

BACKGROUND: In several countries, the dolutegravir (DTG)-based regimen is generally preferred as first-line antiretroviral therapy (ART) over the efavirenz (EFV)-based regimen, but the evidence in low-income countries is limited. OBJECTIVE: Our study aimed to evaluate the cost effectiveness of DTG-...

Descripción completa

Detalles Bibliográficos
Autores principales: Belay, Yared Belete, Ali, Eskinder Eshetu, Chung, Karen Y., Gebretekle, Gebremedhin Beedemariam, Sander, Beate
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8611130/
https://www.ncbi.nlm.nih.gov/pubmed/34133017
http://dx.doi.org/10.1007/s41669-021-00275-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8611130/
https://www.ncbi.nlm.nih.gov/pubmed/34133017
http://dx.doi.org/10.1007/s41669-021-00275-6

Ejemplares similares